Back

The association of NT-proBNP levels in atrial fibrillation patients and 3-year risk of heart hospitalization and death

30 August 2024 (12:00 - 12:40)
Organised by: Logo
Congress Presentation Part of: Risk assessment and prognosis in atrial fibrillation Heart Failure in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Karolina Szummer

Karolinska University Hospital, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
Invasive haemodynamic assessment shows the obesity-HFpEF phenotype is common amongst patients with symptomatic AF
Doctor J. Ariyaratnam (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
Ambulatory polygraphy as a screening tool for obstructive sleep apnea in combination with semi-continuous rhythm monitoring in patients with atrial fibrillation: a pilot study
Miss R. Onder (Hasselt, BE)
Abstract Slides Video
Presentation thumbnail
Risk and causes of hospital admission in patients with atrial fibrillation on treatment with oral anticoagulants
Doctor A. Pannunzio (Rome, IT)
Abstract Slides Video
Presentation thumbnail
An external validation of DOAC score in patients with atrial fibrillation following transcatheter aortic valve replacement
Doctor Y. Harano (Gifu, JP)
Abstract Slides Video
Presentation thumbnail
Novel predictor of thrombosis after left atrial appendage closure -Neutrophil to Lymphocyte Ratio (NLR), platelet to LymPhocyte Ratio (PLR), and Lymphocyte to Monocyte Ratio (LMR)-.
Doctor S. Ryuzaki (Chiba, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Risk assessment and prognosis in atrial fibrillation

The Event

Event poster

ESC Congress 2024

30 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Session
The interplay between atrial fibrillation and heart failure: implications for clinicians
thumbnail
Congress Presentation
Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study
thumbnail
Congress Presentation
Utility of NT-proBNP for detecting heart failure and assessing prognosis in elderly myocardial infarction survivors: insights from the OMEMI trial

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources